
Diego A. Díaz García/X
Apr 14, 2025, 11:29
Diego A Díaz García: MSI-H/dMMR cancers – biology, impact and therapeutic evolution
Diego A Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared a post on X:
“MSI-H/dMMR cancers: biology, impact and therapeutic evolution.
A distinct, immunogenic subtype:
-High ICI sensitivity
-Lynch syndrome link
-Key in CRC, endometrial and more
-Now targeted in early stages too
Histology-agnostic precision at its best.”
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
Authors: Margherita Ambrosini et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 10:23
Apr 15, 2025, 10:22
Apr 15, 2025, 10:17
Apr 15, 2025, 10:09
Apr 15, 2025, 10:04
Apr 15, 2025, 09:54
Apr 15, 2025, 09:48
Apr 15, 2025, 09:45
Apr 15, 2025, 09:37
Apr 15, 2025, 09:34
Apr 15, 2025, 09:30